Status:
COMPLETED
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Immunologic Deficiency Syndromes
Neoplasms
Eligibility:
All Genders
Brief Summary
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency...
Detailed Description
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency...
Eligibility Criteria
Patients will be studied if a disorder of the immune system is suspected.
Key Trial Info
Start Date :
April 1 1977
Trial Type :
OBSERVATIONAL
End Date :
March 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001158
Start Date
April 1 1977
End Date
March 1 2000
Last Update
March 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892